Patents Assigned to Sentoclone AB
  • Composition Comprising In Vitro Expanded T-Lymphocytes and Vessel Formation Inhibitors Suitable in the Treatment of Cancer
    Publication number: 20100015161
    Abstract: Improved cancer therapy using a combination treatment with tumour-reactive T-lymphocytes obtained by an in vitro method for expansion and activation of tumour-reactive lymphocytes, in particular CD4+ helper and/or CD8+ T-lymphocytes and inhibitors of vessel formation inhibitors, notably inhibitors of VEGF.
    Type: Application
    Filed: July 17, 2009
    Publication date: January 21, 2010
    Applicant: Sentoclone AB
    Inventors: Ola Winqvist, Magnus Thörn